{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:45:55Z","timestamp":1793994355466,"version":"4.8.0"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chilblains were first described over a hundred years ago as cutaneous inflammatory lesions, typically on the digits, occurring on cold exposure. Chilblains can be primary, or secondary to a number of conditions such as infections, including COVID-19, and immune-mediated inflammatory disorders (IMIDs) with SLE being the commonest. Chilblain lupus erythematosus (CHLE) was first described in 1888 as cold-induced erythematous lesions before the terms \u2018chilblains\u2019 or \u2018perniosis\u2019 were coined. Diagnostic criteria exist for both chilblains and CHLE. Histopathologically, CHLE lesions show interface dermatitis with perivascular lymphocytic infiltrate. Immunofluorescence demonstrates linear deposits of immunoglobulins and complement in the dermo-epidermal junction. This narrative review focuses on chilblains secondary to immune-mediated inflammatory disorders, primarily the epidemiology, pathogenesis and treatment of CHLE.<\/jats:p>","DOI":"10.1093\/rheumatology\/keac231","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T11:17:55Z","timestamp":1649935075000},"page":"4631-4642","source":"Crossref","is-referenced-by-count":36,"title":["Chilblains in immune-mediated inflammatory diseases: a review"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9979-6066","authenticated-orcid":false,"given":"Shirish","family":"Dubey","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Oxford University Hospitals NHS FT"},{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilay","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kettering general Hospital NHS FT , Kettering"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kettering general Hospital NHS FT , Kettering"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1244-6443","authenticated-orcid":false,"given":"Caroline","family":"Gordon","sequence":"additional","affiliation":[{"name":"Rheumatology Research Group\u2014Institute of Inflammation and Ageing (IIA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8962-4404","authenticated-orcid":false,"given":"John A","family":"Reynolds","sequence":"additional","affiliation":[{"name":"John A Reynolds Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham"},{"name":"Rheumatology Department, Sandwell and West Birmingham NHS Trust , Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"2022112912430303100_keac231-B1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/jdv.12199","article-title":"Demographical, laboratory and associated findings in patients with perniosis","volume":"28","author":"K\u00fclc\u00fc \u00c7akmak","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022112912430303100_keac231-B2","first-page":"960","volume-title":"Textbook of dermatology","author":"Dowd","year":"1998","edition":"6th edn"},{"key":"2022112912430303100_keac231-B3","first-page":"1499","volume-title":"Fitzpatrick\u2019s dermatology in general medicine","author":"Ryan","year":"1999","edition":"5th edn"},{"key":"2022112912430303100_keac231-B4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000247494","article-title":"Chilblain lupus erythematosus: report of 15 cases","volume":"184","author":"Doutre","year":"1992","journal-title":"Dermatology"},{"key":"2022112912430303100_keac231-B5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2133.1978.tb01935.x","article-title":"Chilblain lupus erythematosus (Hutchinson). A clinical and laboratory study of 17 patients","volume":"98","author":"Millard","year":"1978","journal-title":"Br J Dermatol"},{"key":"2022112912430303100_keac231-B6","volume-title":"Encyclopaedia Britannica, or a dictionary of arts, sciences, and miscellaneous literature","year":"1823"},{"key":"2022112912430303100_keac231-B7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10067-008-0942-9","article-title":"Chilblain lupus erythematosus \u2013 a review of literature","volume":"27","author":"Hedrich","year":"2008","journal-title":"Clin Rheumatol"},{"key":"2022112912430303100_keac231-B8","first-page":"108","article-title":"Dermatological aspects of sarcoidosis","volume":"28","author":"James","year":"1959","journal-title":"Q J Med"},{"key":"2022112912430303100_keac231-B9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00005792-200105000-00004","article-title":"Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus","volume":"80","author":"Viguier","year":"2001","journal-title":"Medicine"},{"key":"2022112912430303100_keac231-B10","first-page":"395","article-title":"Chilblains lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria","volume":"54","author":"Su","year":"1994","journal-title":"Cutis"},{"key":"2022112912430303100_keac231-B11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/bmj.1.1411.58","article-title":"Harveian lectures on lupus: the varieties of common lupus","volume":"1","author":"Hutchinson","year":"1888","journal-title":"Br Med J"},{"key":"2022112912430303100_keac231-B12","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022112912430303100_keac231-B13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","author":"Galv\u00e1n Casas","year":"2020","journal-title":"Br J Dermatol"},{"key":"2022112912430303100_keac231-B14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.2010.09829.x","article-title":"Chilblains and antiphospholipid antibodies: report of four cases and review of the literature","volume":"163","author":"Lutz","year":"2010","journal-title":"Br J Dermatol"},{"key":"2022112912430303100_keac231-B15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1590\/abd1806-4841.20142376","article-title":"Chilblains in Turkey: a case-control study","volume":"89","author":"Akkurt","year":"2014","journal-title":"An Bras Dermatol"},{"key":"2022112912430303100_keac231-B16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2340\/00015555-0918","article-title":"Acute perniosis in elderly people: a predictive sign of systemic disease?","volume":"90","author":"Guadagni","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"2022112912430303100_keac231-B17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1525-1470.2000.01722.x","article-title":"Childhood pernio and cryoproteins","volume":"17","author":"Weston","year":"2000","journal-title":"Pediatric Derm"},{"key":"2022112912430303100_keac231-B18","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jaad.2009.10.030","article-title":"Adult perniosis and cryoglobulinemia: a retrospective study and review of the literature","volume":"62","author":"Yang","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"2022112912430303100_keac231-B19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1752-1947-8-381","article-title":"Chilblains in Southern California: two case reports and a review of the literature","volume":"22","author":"Gordon","year":"2014","journal-title":"J Med Case Rep"},{"key":"2022112912430303100_keac231-B20","doi-asserted-by":"crossref","first-page":"01","DOI":"10.14302\/issn.2471-2175.jdrt-15-718","article-title":"A case of pernio associated with cold agglutinin positivity in an unusual location","volume":"1","author":"G\u00f6n\u00fcl","year":"2016","journal-title":"J Dermatol Res Ther"},{"key":"2022112912430303100_keac231-B21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1365-2230.2012.04435.x","article-title":"Epidemiological patterns of perniosis, and its association with systemic disorder","volume":"37","author":"Takci","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"2022112912430303100_keac231-B22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2708","article-title":"Chronic chilblains","author":"Souwer","year":"2011","journal-title":"BMJ"},{"key":"2022112912430303100_keac231-B23","doi-asserted-by":"crossref","first-page":"e74\u20135","DOI":"10.1111\/pde.13366","article-title":"Pernio as the presenting sign of blast crisis in acute lymphoblastic leukemia","volume":"35","author":"Park","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"2022112912430303100_keac231-B24","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archderm.1985.01660080102025","article-title":"Pernio. A possible association with chronic myelomonocytic leukemia","volume":"121","author":"Kelly","year":"1985","journal-title":"Arch Dermatol"},{"key":"2022112912430303100_keac231-B25","first-page":"836","article-title":"Leukaemia cutis presenting as digital and chilblain-like perniosis","volume":"20","author":"Al-Niaimi","year":"2010","journal-title":"Eur J Dermatol"},{"key":"2022112912430303100_keac231-B26","first-page":"494","article-title":"Chilblain lupus erythematosus as a manifestation of lymphoma","volume":"60","author":"Marks","year":"1967","journal-title":"Proc R Soc Med"},{"key":"2022112912430303100_keac231-B27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.1780240921","article-title":"Unusual pernio-like reaction to sulindac","volume":"24","author":"Reinertsen","year":"1981","journal-title":"Arthritis Rheum"},{"key":"2022112912430303100_keac231-B28","first-page":"760","article-title":"Infliximab induced chilblain lupus in a patient with rheumatoid arthritis","volume":"32","author":"Richez","year":"2005","journal-title":"J Rheumatol"},{"key":"2022112912430303100_keac231-B29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10067-011-1924-x","article-title":"Chilblain lupus induced by TNF-\u03b1 antagonists: a case report and literature review","volume":"31","author":"Sifuentes Giraldo","year":"2012","journal-title":"Clin Rheumatol"},{"key":"2022112912430303100_keac231-B30","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jdcr.2019.07.013","article-title":"Posttraumatic unilateral perniosis: a case report","volume":"5","author":"Boesjes","year":"2019","journal-title":"JAAD Case Rep"},{"key":"2022112912430303100_keac231-B31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2230.1993.tb02248.x","article-title":"Pregnancy-induced chilblain lupus erythematosus","volume":"18","author":"Stainforth","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"2022112912430303100_keac231-B32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2133.1996.tb01495.x","article-title":"Cutaneous manifestations of systemic lupus erythematosus","volume":"135","author":"Yell","year":"1996","journal-title":"Br J Dermatol"},{"key":"2022112912430303100_keac231-B33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2133.1960.tb13883.x","article-title":"Progress in the understanding of lupus erythematosus","volume":"72","author":"Gold","year":"1960","journal-title":"Br J Dermatol"},{"key":"2022112912430303100_keac231-B34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0961203306075792","article-title":"Cutaneous lesions of the digits in systemic lupus erythematosus: 50 cases","volume":"16","author":"Bouaziz","year":"2007","journal-title":"Lupus"},{"key":"2022112912430303100_keac231-B35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1191\/096120399678847632","article-title":"Chilblain lupus erythematosus is associated with antibodies to SSA\/Ro","volume":"8","author":"Franceschini","year":"1999","journal-title":"Lupus"},{"key":"2022112912430303100_keac231-B36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2133.1996.tb16244.x","article-title":"Chilblain lupus erythematosus of Hutchinson responding to surgical treatment: a report of two patients with anti-Ro\/SS-A antibodies","volume":"134","author":"Aoki","year":"1996","journal-title":"Br J Dermatol"},{"key":"2022112912430303100_keac231-B37","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jaad.2013.04.020","article-title":"Systemic involvement in TREX1-associated familial chilblain lupus","volume":"69","author":"G\u00fcnther","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2022112912430303100_keac231-B38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jaad.2009.05.002","article-title":"Blue (or purple) toes: chilblains or chilblain lupus-like lesions are a manifestation of Aicardi-Gouti\u00e8res syndrome and familial chilblain lupus","volume":"61","author":"Prendiville","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"2022112912430303100_keac231-B39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi\u2013Gouti\u00e8res syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2022112912430303100_keac231-B40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/annrheumdis-2016-209841","article-title":"Familial chilblain lupus due to a gain-of-function mutation in STING","volume":"76","author":"K\u00f6nig","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022112912430303100_keac231-B41","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2022112912430303100_keac231-B42","doi-asserted-by":"crossref","first-page":"595739","DOI":"10.3389\/fimmu.2020.595739","article-title":"The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19","volume":"11","author":"Schreiber","year":"2020","journal-title":"Front. Immunol"},{"key":"2022112912430303100_keac231-B43","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaad.2020.04.161","article-title":"Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France","volume":"83","author":"de Masson","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2022112912430303100_keac231-B44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjd.19327","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases","volume":"183","author":"Colmenero","year":"2020","journal-title":"Br J Dermatol"},{"key":"2022112912430303100_keac231-B45","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2020.05.145","article-title":"Chilblain-like acral lesions during the COVID-19 pandemic (\"COVID toes\"): histologic, immunofluorescence, and immunohistochemical study of 17 cases","volume":"83","author":"Kanitakis","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2022112912430303100_keac231-B46","doi-asserted-by":"crossref","DOI":"10.5070\/D32612051347","article-title":"Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data","volume":"26","author":"Lee","year":"2020","journal-title":"Dermatol Online J"},{"key":"2022112912430303100_keac231-B47","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/jdv.16682","article-title":"A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection","volume":"34","author":"El Hachem","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022112912430303100_keac231-B48","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/ijd.15422","article-title":"Pseudo-chilblain lesions and COVID-19: a controversial relationship","volume":"60","author":"V\u00e1zquez-Osorio","year":"2021","journal-title":"Int J Dermatol"},{"key":"2022112912430303100_keac231-B49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.mayocp.2013.09.020","article-title":"Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to 2011","volume":"89","author":"Cappel","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"2022112912430303100_keac231-B50","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0190-9622(88)80377-3","article-title":"Chilblain lupus erythematosus and antiphospholipid antibody syndrome","volume":"19","author":"Allegue","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"2022112912430303100_keac231-B51","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1067\/mjd.2001.117861","article-title":"A histologic and immunohistochemical study of chilblains","volume":"45","author":"Cribier","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"2022112912430303100_keac231-B52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2007.09.039","article-title":"Comparison of histopathologic-clinical characteristics of Jessner's lym-phocytic in\ufb01ltration of the skin and lupus erythematosus tumidus: multicenter study of 46 cases","volume":"58","author":"R\u00e9my-Leroux","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2022112912430303100_keac231-B53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/DAD.0b013e3181af1d24","article-title":"Perniosis: clinical and histopathological analysis","volume":"32","author":"Boada","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"2022112912430303100_keac231-B54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/DAD.0000000000000945","article-title":"Comparative analysis of chilblain lupus erythematosus and idiopathic perniosis: histopathologic features and immunohistochemistry for CD123 and CD30","volume":"40","author":"Wang","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"2022112912430303100_keac231-B55","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.3399\/bjgp17X689413","article-title":"Assessing the effectiveness of topical betamethasone to treat chronic chilblains: a randomised clinical trial in primary care","volume":"67","author":"Souwer","year":"2017","journal-title":"Br J Gen Pract"},{"key":"2022112912430303100_keac231-B56","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/bmj.293.6552.923-a","article-title":"Nifedipine in the treatment of chilblains","volume":"293","author":"Dowd","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2022112912430303100_keac231-B57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.1989.tb07792.x","article-title":"The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trial","volume":"120","author":"Rustin","year":"1989","journal-title":"Br J Dermatol"},{"key":"2022112912430303100_keac231-B58","first-page":"209","article-title":"Diltiazem vs. nifedipine in chilblains: a clinical trial","volume":"69","author":"Patra","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2022112912430303100_keac231-B59","first-page":"342","article-title":"K. Comparison of efficacy and safety of topical glyceryl trinitrate vs. oral nifedipine in idiopathic perniosis: results of a randomized clinical trial","volume":"24","author":"Khalid","year":"2014","journal-title":"JPAD"},{"key":"2022112912430303100_keac231-B60","first-page":"40","article-title":"Treatment of perniosis with oral nifedipine in comparison with topical 5% minoxidil solution in Iraqi patients: single blind comparative study","volume":"8","author":"Kubais","year":"2010","journal-title":"Al-Anbar Med J"},{"key":"2022112912430303100_keac231-B61","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1370\/afm.1966","article-title":"Nifedipine vs placebo for treatment of chronic chilblains: a randomized controlled trial","volume":"14","author":"Souwer","year":"2016","journal-title":"Ann Fam Med"},{"key":"2022112912430303100_keac231-B62","first-page":"62","article-title":"A random comparative therapeutic trial of oral nifedipine v\/s topical 5% minoxidil gel in patients of perniosis at a tertiary care center of North-western India","volume":"4","author":"Jain","year":"2018","journal-title":"Indian J Clin Exp Dermatol"},{"key":"2022112912430303100_keac231-B63","first-page":"1762","article-title":"Treatment of perniosis with oral pentoxyfylline in comparison with oral prednisolone plus topical clobetasol ointment in Iraqi patients","volume":"29","author":"Noaimi","year":"2008","journal-title":"Saudi Med J"},{"key":"2022112912430303100_keac231-B64","doi-asserted-by":"crossref","first-page":"210","DOI":"10.32007\/med.1936\/jfacmedbagdad.v57i3.7","article-title":"Treatment of perniosis with oral tadalafil, pentoxifylline or prednisolone: a therapeutic comparative study","volume":"57","author":"Noaimi","year":"2015","journal-title":"J Fac Med Baghdad"},{"key":"2022112912430303100_keac231-B65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/dth.12350","article-title":"Treatment of primary perniosis with oral\u00a0pentoxifylline (a double-blind placebo-controlled randomized therapeutic trial)","volume":"29","author":"Al-Sudany","year":"2016","journal-title":"Dermatol Ther"},{"key":"2022112912430303100_keac231-B66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2133.2005.06552.x","article-title":"Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients","volume":"153","author":"Wenzel","year":"2005","journal-title":"Br J Dermatol"},{"key":"2022112912430303100_keac231-B67","first-page":"447"},{"key":"2022112912430303100_keac231-B68","first-page":"512","article-title":"Chilblains","volume":"10","author":"Chipman","year":"1912","journal-title":"Cal State J Med"},{"key":"2022112912430303100_keac231-B69","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/bjd.15312","article-title":"Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis","volume":"177","author":"Chasset","year":"2017","journal-title":"Br J Dermatol"},{"key":"2022112912430303100_keac231-B70","first-page":"1242","article-title":"Successful treatment of perniosis with hydroxychloroquine","volume":"9","author":"Yang","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"2022112912430303100_keac231-B71","doi-asserted-by":"crossref","first-page":"bcr2013201165","DOI":"10.1136\/bcr-2013-201165","article-title":"Chilblain lupus erythematosus","volume":"2013","author":"Patel","year":"2013","journal-title":"BMJ Case Rep"},{"key":"2022112912430303100_keac231-B72","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1097\/RHU.0000000000001061","article-title":"Hydroxychloroquine-associated hyperpigmentation in chilblain lupus erythematosus","volume":"26","author":"Horino","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"2022112912430303100_keac231-B73","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1111\/ijd.13614","article-title":"Chilblain lupus erythematosus treated successfully with mycophenolate mofetil","volume":"56","author":"Gouillon","year":"2017","journal-title":"Int J Dermatol"},{"key":"2022112912430303100_keac231-B74","first-page":"235","article-title":"Chilblain lupus erythematosus Hutchinson: successful treatment with mycophenolate mofetil","volume":"137","author":"Boehm","year":"2001","journal-title":"Arch Dermatol"},{"key":"2022112912430303100_keac231-B75","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaad.2010.08.011","article-title":"Ef\ufb01cacity of mycophenolate mofetil in antimalarial resistant cutaneous lupus erythematosus","volume":"65","author":"Gammon","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2022112912430303100_keac231-B76","first-page":"49","article-title":"Chilblain lupus erythematosus with response to chemical sympathectomy","volume":"101","author":"Breathnach","year":"1979","journal-title":"Br J Dermatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac231\/43754268\/keac231.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/12\/4631\/47385850\/keac231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/12\/4631\/47385850\/keac231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T23:33:15Z","timestamp":1675294395000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/12\/4631\/6567352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":76,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,4,12]]},"published-print":{"date-parts":[[2022,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac231","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,4,12]]}}}